Dudum Andrew's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Dec 4, 2023
- Accession no.
- 0001773751-23-000284
- Filed
- Dec 4, 2023
- Trade date
- Nov 30-Dec 1, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $253.7K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001773751-23-000289 (Dec 15, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudum AndrewCIK 0001837796 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2023 | Class A Common Stock | MOption exerciseAcquired | +3,800 | $2.43 | +$9,234 | 3,800 | Direct | |
| Nov 30, 2023 | Class A Common Stock | SSaleDisposed | −3,800 | $9.01F2 | −$34,238 | 0 | Direct | |
| Dec 1, 2023 | Class A Common Stock | MOption exerciseAcquired | +24,300 | $2.43 | +$59,049 | 24,300 | Direct | |
| Dec 1, 2023 | Class A Common Stock | SSaleDisposed | −24,300 | $9.03F3 | −$219,429 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2023 | Class A Common Stock | MOption exerciseDisposed | −3,800 | $0.00 | $0 | 3,012,064 | Direct | |
| Dec 1, 2023 | Class A Common Stock | MOption exerciseDisposed | −24,300 | $0.00 | $0 | 2,987,764 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.02. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.075. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.